Memphasys has developed RoXsta™, a revolutionary oxidative stress testing system that reduces analysis time from hours to six minutes. With broad application across fertility, diagnostics, and animal health, RoXsta™ represents a significant leap forward in point-of-care and lab-based oxidative stress diagnostics.
I am hoping that the company is seeking strategic partners to support co-development, distribution, validation, and commercialization as we move toward a fully integrated, point-of-care device.
Fertility Clinics: Oxidative stress is implicated in 30–80% of male infertility cases. RoXsta™ offers fast, reliable results for improved diagnosis and treatment planning.
Veterinary & Livestock Applications: Rapid sperm quality testing in animals enhances breeding outcomes and herd productivity.
Clinical Diagnostics: Chronic diseases such as cardiovascular, metabolic, and inflammatory disorders are linked to oxidative stress.
Wellness & Anti-Aging: Growing demand for biomarker-based personalization in supplements and longevity therapies.
What Makes RoXsta™ a Game Changer?
Speed: Results in 6 minutes vs. 6–16 hours in traditional methods
High Throughput: 96 samples per hour demonstrated in trials
Versatility: Compatible with sperm, blood, and other biological samples
Scalability: Designed for lab and future point-of-care formats
Did some research and here are some options for strategic Partners
Partner Strategic Fit Why Now? Virtus Health Fertility network, known collaborator Early adopter for fertility clinics CooperSurgical (because Vitrolife are useless) Global ART leader RoXsta enhances male fertility assessment Zoetis Global animal health firm Animal sperm quality testing for livestock BioMérieux Diagnostics giant Co-develop oxidative stress testing workflows Thorne HealthTech Personalized health innovator Leverage RoXsta for wellness biomarkers
What might the partnership look like?
- Co-develop specialized versions (e.g., fertility, animal health, wellness)
Validate in clinical/field settings
Scale manufacturing and secure regulatory pathways
Some of these companies may already be looking at this. Any one of these would see us sky rocket to 5c+ I'm ready, I've been ready for years ROFL
Just thought of another big one, CSL
- Forums
- ASX - By Stock
- MEM
- RoXsta, the real Rock Star
MEM
memphasys limited.
Add to My Watchlist
25.0%
!
0.5¢

RoXsta, the real Rock Star, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.5¢ |
Change
0.001(25.0%) |
Mkt cap ! $9.917M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.5¢ | $500 | 100K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
18 | 7121027 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 2473916 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
18 | 7121027 | 0.004 |
7 | 3473000 | 0.003 |
7 | 25894000 | 0.002 |
5 | 7850000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 2473916 | 3 |
0.006 | 7504481 | 13 |
0.007 | 9744169 | 9 |
0.008 | 2884385 | 8 |
0.009 | 1180000 | 2 |
Last trade - 10.04am 18/06/2025 (20 minute delay) ? |
Featured News
MEM (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online